Carlsbad, CA, United States of America

Mark D Cochran

USPTO Granted Patents = 63 


 

Average Co-Inventor Count = 2.1

ph-index = 16

Forward Citations = 821(Granted Patents)

Forward Citations (Not Self Cited) = 706(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • La Jolla, CA (US) (1989 - 1991)
  • Carlsband, CA (US) (1999 - 2002)
  • Carlsbad, CA (US) (1991 - 2011)

Company Filing History:


Years Active: 1989-2011

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Feline CD86 Polypeptides
Recombinant Clostridium Organisms
Infectious Laryngotracheitis Virus
GDF8 Epitope-Based Vaccines
Recombinant Avian Herpesvirus
Recombinant Swinepox Virus
Recombinant Bovine Rhinotracheitis Virus
Chimeric Viruses
Recombinant Fowlpox Viruses
Recombinant Herpesvirus of Turkeys
Genetically-Engineered Viruses
63 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Inventor Mark D Cochran

Introduction:

Inventor Mark D Cochran hails from Carlsbad, California, and has an impressive portfolio of 63 patents to his name. His groundbreaking work in various fields such as feline genetics and vaccine development has significantly contributed to the advancements in the medical and veterinary industries.

Latest Patents:

One of his latest patents revolves around Feline CD86 polypeptides and nucleic acids, which entail isolated DNA encoding crucial feline immune receptors and ligands. This invention showcases his expertise in molecular biology and vaccine design, offering novel avenues for enhancing immune responses in feline populations.

Additionally, Cochran's work on recombinant attenuated clostridium organisms and vaccines highlights his innovative approach in developing safer and more effective vaccination strategies. By targeting specific toxin proteins and engineering attenuated organisms, he has paved the way for the production of advanced vaccines with enhanced efficacy.

Career Highlights:

Throughout his career, Cochran has been associated with prominent companies like Syntro Corporation and Schering-Plough Animal Health Corporation. His tenure at these organizations has been marked by groundbreaking research and technological innovations that have shaped the landscape of veterinary medicine and biotechnology.

Collaborations:

In his professional journey, Cochran has collaborated with esteemed coworkers such as David E Junker and Richard D Macdonald. These collaborations have fostered a spirit of innovation and knowledge exchange, leading to the development of cutting-edge technologies and solutions in the realm of animal health and feline genetics.

Conclusion:

Inventor Mark D Cochran's remarkable contributions to the fields of feline genetics, vaccine development, and biotechnology exemplify his unwavering dedication to innovation and scientific excellence. His legacy continues to inspire future generations of inventors and researchers to push the boundaries of knowledge and drive positive change in the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…